BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29954950)

  • 1. Effects of flanking regions on HDV cotranscriptional folding kinetics.
    Wang Y; Wang Z; Liu T; Gong S; Zhang W
    RNA; 2018 Sep; 24(9):1229-1240. PubMed ID: 29954950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots.
    Chadalavada DM; Senchak SE; Bevilacqua PC
    J Mol Biol; 2002 Apr; 317(4):559-75. PubMed ID: 11955009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic partitioning mechanism of HDV ribozyme folding.
    Chen J; Gong S; Wang Y; Zhang W
    J Chem Phys; 2014 Jan; 140(2):025102. PubMed ID: 24437918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type is the optimal sequence of the HDV ribozyme under cotranscriptional conditions.
    Chadalavada DM; Cerrone-Szakal AL; Bevilacqua PC
    RNA; 2007 Dec; 13(12):2189-201. PubMed ID: 17956974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential folding of the genomic ribozyme of the hepatitis delta virus: structural analysis of RNA transcription intermediates.
    Matysiak M; Wrzesinski J; Ciesiołka J
    J Mol Biol; 1999 Aug; 291(2):283-94. PubMed ID: 10438621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for upstream RNA structure in facilitating the catalytic fold of the genomic hepatitis delta virus ribozyme.
    Chadalavada DM; Knudsen SM; Nakano S; Bevilacqua PC
    J Mol Biol; 2000 Aug; 301(2):349-67. PubMed ID: 10926514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotranscriptional 3'-End Processing of T7 RNA Polymerase Transcripts by a Smaller HDV Ribozyme.
    Akoopie A; Müller UF
    J Mol Evol; 2018 Aug; 86(7):425-430. PubMed ID: 30099590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.
    Jeng KS; Daniel A; Lai MM
    J Virol; 1996 Apr; 70(4):2403-10. PubMed ID: 8642668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a highly reactive HDV ribozyme sequence uncovers facilitation of RNA folding by alternative pairings and physiological ionic strength.
    Brown TS; Chadalavada DM; Bevilacqua PC
    J Mol Biol; 2004 Aug; 341(3):695-712. PubMed ID: 15288780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse RNA Folding Workflow to Design and Test Ribozymes that Include Pseudoknots.
    Kayedkhordeh M; Yamagami R; Bevilacqua PC; Mathews DH
    Methods Mol Biol; 2021; 2167():113-143. PubMed ID: 32712918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic framework for co-transcriptional folding of the HDV genomic ribozyme in the presence of downstream sequence.
    Diegelman-Parente A; Bevilacqua PC
    J Mol Biol; 2002 Nov; 324(1):1-16. PubMed ID: 12421555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes.
    Wadkins TS; Perrotta AT; Ferré-D'Amaré AR; Doudna JA; Been MD
    RNA; 1999 Jun; 5(6):720-7. PubMed ID: 10376872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The poly(A) site sequence in HDV RNA alters both extent and rate of self-cleavage of the antigenomic ribozyme.
    Brown AL; Perrotta AT; Wadkins TS; Been MD
    Nucleic Acids Res; 2008 May; 36(9):2990-3000. PubMed ID: 18388129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate HDV ribozyme crystal structures represent intermediates on a rugged free-energy landscape.
    Sripathi KN; Tay WW; Banáš P; Otyepka M; Šponer J; Walter NG
    RNA; 2014 Jul; 20(7):1112-28. PubMed ID: 24854621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses.
    Tanner NK; Schaff S; Thill G; Petit-Koskas E; Crain-Denoyelle AM; Westhof E
    Curr Biol; 1994 Jun; 4(6):488-98. PubMed ID: 7922369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructing an efficient trans-acting genomic HDV ribozyme.
    Kawakami J; Yuda K; Suh YA; Kumar PK; Nishikawa F; Maeda H; Taira K; Ohtsuka E; Nishikawa S
    FEBS Lett; 1996 Sep; 394(2):132-6. PubMed ID: 8843150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nondenaturing purification of co-transcriptionally folded RNA avoids common folding heterogeneity.
    Pereira MJ; Behera V; Walter NG
    PLoS One; 2010 Sep; 5(9):e12953. PubMed ID: 20886091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.
    Cerrone-Szakal AL; Chadalavada DM; Golden BL; Bevilacqua PC
    RNA; 2008 Sep; 14(9):1746-60. PubMed ID: 18658121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.